Application of Artificial Neural Networks for modeling drug release from a bicomponent hydrogel system
暂无分享,去创建一个
Tiberius Dumitriu | Vasile Manta | Raluca Petronela Dumitriu | V. Manta | R. Dumitriu | Tiberius Dumitriu
[1] J. Parojčić,et al. Artificial neural networks in the modeling and optimization of aspirin extended release tablets with eudragit L 100 as matrix substance , 2008, AAPS PharmSciTech.
[2] Seyedmohsen Hosseini,et al. A survey on the Imperialist Competitive Algorithm metaheuristic: Implementation in engineering domain and directions for future research , 2014, Appl. Soft Comput..
[3] Caro Lucas,et al. Imperialist competitive algorithm: An algorithm for optimization inspired by imperialistic competition , 2007, 2007 IEEE Congress on Evolutionary Computation.
[4] R L Savage,et al. Variation in the risk of peptic ulcer complications with nonsteroidal antiinflammatory drug therapy. , 1993, Arthritis and rheumatism.
[5] Renata Jachowicz,et al. pplication of artificial neural networks ( ANNs ) and genetic programming ( GP ) or prediction of drug release from solid lipid matrices , 2012 .
[6] Sean C. Sweetman,et al. Martindale: The Complete Drug Reference , 1999 .
[7] Jun-Lin Lin,et al. Interaction Enhanced Imperialist Competitive Algorithms , 2012, Algorithms.
[8] Geoffrey R. Mitchell,et al. Multi-responsive hydrogels based on N-isopropylacrylamide and sodium alginate , 2011 .
[9] Tiberius Dumitriu. A novel hybrid approach of Evolutionary Algorithm based on Imperialist Competitive Algorithm , 2015, 2015 19th International Conference on System Theory, Control and Computing (ICSTCC).
[10] George Cybenko,et al. Approximation by superpositions of a sigmoidal function , 1992, Math. Control. Signals Syst..
[11] A. Ghaffari,et al. Performance comparison of neural network training algorithms in modeling of bimodal drug delivery. , 2006, International journal of pharmaceutics.
[12] P. Grootendorst,et al. Optimization of controlled release nanoparticle formulation of verapamil hydrochloride using artificial neural networks with genetic algorithm and response surface methodology. , 2015, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[13] Jelena Parojčić,et al. Artificial Neural Networks in Evaluation and Optimization of Modified Release Solid Dosage Forms , 2012, Pharmaceutics.
[14] Lei Zhai,et al. Controlled drug release from porous polyelectrolyte multilayers. , 2006, Biomacromolecules.
[15] Raluca Petronela Dumitriu,et al. Biocompatible and biodegradable alginate/poly(N‐isopropylacrylamide) hydrogels for sustained theophylline release , 2014 .
[16] M. Benrejeb,et al. On the Use of Neural Network as a Universal Approximator , 2008 .
[17] Kurt Hornik,et al. Approximation capabilities of multilayer feedforward networks , 1991, Neural Networks.
[18] J. Parojčić,et al. Application of dynamic neural networks in the modeling of drug release from polyethylene oxide matrix tablets. , 2009, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[19] J Bourquin,et al. Basic concepts of artificial neural networks (ANN) modeling in the application to pharmaceutical development. , 1997, Pharmaceutical development and technology.
[20] Martin H. Abramson,et al. Complete Drug Reference , 1996 .
[21] V. Lambert,et al. Arthritis , 1991, Annual Review of Nursing Research.
[22] Mark Collen,et al. Pharmacotherapy , 2008 .